The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shanta Somani & PAC
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mrs. Shanta Somani, along with PAC Citric India Limited (part of the promoter/promoter group), has filed a revised disclosure under SEBI Takeover Regulations reporting a complete exit from Chemo Pharma Laboratories Limited. Before the sale, she held 48,781 equity shares representing 3.25% of the company's share capital. She sold all 48,781 shares on 12 July 2025, bringing her post-sale holding to nil (0%). The total equity share capital of the company is 15,00,000 shares of Rs. 10 each. This is a 100% reduction in her stake from 3.25% to zero.
A full exit by a promoter-group member signals a reduction in promoter ownership, which may be viewed negatively by retail investors as it reduces insider skin-in-the-game. The stock could see short-term pressure, though the stake being relatively small (3.25%) limits the material impact on share price.